https://wetvhappyworkingclub.com/%e0%b8%aa%e0%b8%99%e0%b8%b2%e0%b8%a1%e0%b8%81%e0%b8%b5%e0%b8%ac%e0%b8%b2%e0%b8%97%e0%b8%b5%e0%b9%88%e0%b9%83%e0%b8%ab%e0%b8%8d%e0%b9%88%e0%b8%97%e0%b8%b5%e0%b9%88%e0%b8%aa%e0%b8%b8%e0%b8%94%e0%b8%82/ https://wetvhappyworkingclub.com/4-%e0%b9%80%e0%b8%8b%e0%b8%b5%e0%b8%a2%e0%b8%99-%e0%b8%a5%e0%b9%89%e0%b8%a1-%e0%b9%82%e0%b8%95%e0%b9%8a%e0%b8%b0-%e0%b9%80%e0%b8%84%e0%b8%a5%e0%b9%87%e0%b8%94%e0%b8%a5%e0%b8%b1%e0%b8%9a%e0%b8%81/ Why for Covid-19 A joint study by Mahidol and Oxford Universities debunks Ivermectin’s antiviral claims for Covid-19 Research underscores the need for evidence-based treatments in combating Covid-19 Ivermectin Research Results from PLATCOV Trial What Was Studied? -scale study focused on repurposed drugs for combating viral infections like Covid-19 Findings on Ivermectin's Performance Patients treated with Ivermectin showed a 9.1% slower viral clearance rate Comparison of Antiviral Effectiveness These outcomes emphasize the importance of relying on evidence-based antiviral treatments Key Takeaways for Covid-19 Management Why Evidence is Crucial in Covid-19 Treatment The study highlights the dangers of adopting unproven treatments during a pandemic Avoiding Unverified Therapies This case highlights the harm caused by misinformation about medical treatments Moving Forward in Covid-19 Research The Mahidol-Oxford study paves the way for more comprehensive antiviral research